Evolent Health
EVH
136 hedge funds and large institutions have $522M invested in Evolent Health in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 43 reducing their positions, and 37 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
20% more capital invested
Capital invested by funds: $434M → $522M (+$88.6M)
7% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 43
2% more call options, than puts
Call options by funds: $1.8M | Put options by funds: $1.77M
6.87% less ownership
Funds ownership: 92.82% → 85.95% (-6.9%)
12% less funds holding
Funds holding: 154 → 136 (-18)
43% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$11M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
+$10.9M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$5.73M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.57M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$3.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$16.9M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$11.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.99M |
| 4 |
Millennium Management
New York
|
-$7.25M |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$5.37M |
EVH Hedge Fund Activity: Q2 2020 in Review
136 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2020, worth a combined $522M — up 20% from $434M a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of EVH and 21 opened new positions — a net loss of 16 holders — while 43 trimmed existing stakes and 46 added.
The largest buyer was Granahan Investment Management, adding an estimated $11M. The largest seller was Riverbridge Partners, cutting an estimated $16.9M.
- 136 institutional investors held Evolent Health (EVH) as of Q2 2020, down from 154 in Q1 2020.
- Funds reported $522M of Evolent Health stock for Q2 2020, up 20% quarter-over-quarter.
- 21 funds opened new Evolent Health positions in Q2 2020 and 37 closed out, a net change of -16 holders.
- The largest Evolent Health buyer in Q2 2020 was Granahan Investment Management, an estimated $11M added.
- The largest Evolent Health seller in Q2 2020 was Riverbridge Partners, an estimated $16.9M sold.
Based on aggregated 13F filings for Q2 2020.